亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

山東廠家現(xiàn)貨維生素C乙基醚86404-04-8

 
 
單價(jià) 1000.00 / 千克對(duì)比
銷(xiāo)量 暫無(wú)
發(fā)貨 山東泰安市付款后3天內(nèi)
庫(kù)存 10000千克起訂1千克
品牌 江舟
名稱 維生素C乙基醚
CAS 86404-04-8
含量 99.5%
過(guò)期 長(zhǎng)期有效
更新 2021-06-17 12:30
 

泰安市江舟生物科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
  • 山東-泰安市
  • 上次登錄 2021-06-17
  • 崔經(jīng)理 (先生)   經(jīng)理
詳細(xì)說(shuō)明
中文名稱:維生素C乙基醚
別名:3-O-乙基抗壞血酸醚;VC乙基醚
英文名稱:3-O-Ethyl-L-ascorbic acid
CAS號(hào):86404-04-8
分子式:C8H12O6
分子量:204.18
EINECS號(hào):617-849-3
外觀:白色結(jié)晶
含量:99.5%
包裝:25KG/紙板桶
用途:化工原料
本公司所售產(chǎn)品均為原料、中間體,并非成品,僅供企業(yè).研究所和院校產(chǎn)品制作和實(shí)驗(yàn)使用.禁止個(gè)人購(gòu)買(mǎi)使用
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
山東廠家現(xiàn)貨麝香-T105-95-3 山東廠家現(xiàn)貨十二烷基琥珀酸酐26544-38-7 山東廠家現(xiàn)貨雙氯芬酸鈉 15307-79-6 山東廠家現(xiàn)貨四丁基脲4559-86-8 山東廠家現(xiàn)貨特丁津5915-41-3 山東廠家現(xiàn)貨維生素C鈣 山東廠家現(xiàn)貨肟菌酯141517-21-7
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |